LIVE TV
LIVE TV
LIVE TV
Home > World > BRIEF-Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106

BRIEF-Antengene Corp Enters Exclusive License Agreement With K2 Therapeutics For Atg-106

Written By: Editorial Webdesk
Published: June 22, 2026 06:52:11 IST

Add NewsX As A Trusted Source

June 22 (Reuters) – Antengene Corp Ltd: * ENTERS EXCLUSIVE LICENSE AGREEMENT WITH K2 THERAPEUTICS FOR ATG-106 * TO RECEIVE ABOUT $20 MILLION UPFRONT AND NEAR-TERM CONSIDERATION Further company

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)

RELATED News

LATEST NEWS